DETAILS, FICTION AND E7449

CRC has an immunosuppressive TME which prevents the event of an efficient reaction to ICB therapies. There exists Therefore an urgent need to identify the approaches reprogram this suppressive TME to be able to enhance immunotherapy efficacy. In The present study, we made use of CRISPR KO screens to find genes that sensitize CRC to antitumor immuni